Allylic C–H oxygenation of unactivated internal olefins by the Cu/azodiformate catalyst system

L Le Wang Y Yuan She (State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering) J Jie Xiao Z Zi-Hao Li (University of British Columbia, Department of Chemistry, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada) S Shen-Yuan Zhang (State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering) P Peng-Fei Lian (School of Pharmaceutical Sciences, Shanghai Key Laboratory of Chiral Drugs and Engineering, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy) T Tong-Mei Ding S Shu-Yu Zhang (State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering)

Abstract

Abstract Allylic ethers and alcohols are essential structural motifs commonly present in natural products and pharmaceuticals. Direct allylic C–H oxygenation of internal alkenes is one of the most direct methods, bypassing the necessity for an allylic leaving group that is needed in the traditional Tsuji–Trost reaction. Herein, we develop an efficient and practical method for synthesizing (E)-allyl ethers from readily available internal alkenes and alcohols or phenols via selective allylic C–H oxidation. Key advances include the use of a Cu/Azodiformate catalyst system to facilitate remote allylic C–H activation and the achievement of excellent chemoselectivity through a dynamic ligand exchange strategy using a bis(sulfonamide) ligand. This method features a broad substrate scope and functional group tolerance, successfully applied to the synthesis of various challenging medium-sized cyclic ethers (7-10 members) and large-ring lactones (14-20 members), with high regioselectivity and stereoselectivity.

Article Details

Volume / Issue Vol. 16, Issue 1
Published January 20, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (8)

L

Le Wang

Y

Yuan She

State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering

J

Jie Xiao

Z

Zi-Hao Li

University of British Columbia, Department of Chemistry, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada

S

Shen-Yuan Zhang

State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering

P

Peng-Fei Lian

School of Pharmaceutical Sciences, Shanghai Key Laboratory of Chiral Drugs and Engineering, Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy

T

Tong-Mei Ding

S

Shu-Yu Zhang

State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering